Payment overview · 2025
General Payments
$8,673.69
129 reported records · 24 companies
Healthcare provider profile · identity verified
John Michael Danks, M.D.
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · PARAMUS, NJ · NPI 1023308772
Verified facts
What the public records show
CMS Open Payments records show John Michael Danks, M.D. received $8,673.69 in general payments during 2025 across 129 reported records.
Integra LifeSciences Corporation accounted for 25.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 50 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Integra LifeSciences Corporation | Unresolved — no canonical attribution shown | $2,222.26 | 25.6% | 8 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $1,456.22 | 16.8% | 6 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $1,372.14 | 15.8% | 19 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $866.50 | 10.0% | 17 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $668.83 | 7.7% | 23 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $330.11 | 3.8% | 6 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $321.57 | 3.7% | 8 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $280.11 | 3.2% | 7 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $242.62 | 2.8% | 2 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $233.83 | 2.7% | 9 | 2025 |
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $179.00 | 2.1% | 2 | 2025 |
| Urgo Medical North America, LLC | Unresolved — no canonical attribution shown | $96.96 | 1.1% | 5 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $83.83 | 1.0% | 3 | 2025 |
| LSI SOLUTIONS INC | Unresolved — no canonical attribution shown | $56.50 | 0.7% | 1 | 2025 |
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $35.55 | 0.4% | 2 | 2025 |
| CashFlow Solutions, LLC | Unresolved — no canonical attribution shown | $31.41 | 0.4% | 2 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $29.73 | 0.3% | 2 | 2025 |
| VentureMed Group, Inc. | Unresolved — no canonical attribution shown | $28.97 | 0.3% | 1 | 2025 |
| LeMaitre Vascular, Inc. | Unresolved — no canonical attribution shown | $26.78 | 0.3% | 1 | 2025 |
| Acera Surgical, Inc. | Unresolved — no canonical attribution shown | $24.63 | 0.3% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $24.30 | 0.3% | 1 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $21.96 | 0.2% | 1 | 2025 |
| Neuros Medical, Inc. | Unresolved — no canonical attribution shown | $20.77 | 0.2% | 1 | 2025 |
| Humacyte Global, Inc. | Unresolved — no canonical attribution shown | $19.11 | 0.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $5,918.76 | 123 |
| Long term medical supply or device loan | $2,151.30 | 5 |
| Travel and Lodging | $603.63 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MicroMatrix Normalized: micromatrix |
Device | Integra LifeSciences Corporation | $2,040.88 | 3 | 2025 |
Source payment records
|
|||||
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $1,456.22 | 6 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $1,456.22 | 6 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $1,121.35 | 15 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $1,121.35 | 15 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $866.50 | 17 | 2025 |
Source payment records
|
|||||
| LUTONIX Drug Coated Balloon Normalized: lutonix drug coated balloon |
Device | Bard Peripheral Vascular, Inc. | $283.71 | 4 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $280.11 | 7 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $255.48 | 5 | 2025 |
Source payment records
|
|||||
| ZENITH SPIRAL-Z Normalized: zenith spiral z |
Device | Cook Medical LLC | $253.96 | 4 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $233.83 | 9 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $214.45 | 2 | 2025 |
Source payment records
|
|||||
| APLIGRAF Normalized: apligraf |
Device | Organogenesis Inc. | $179.00 | 2 | 2025 |
Source payment records
|
|||||
| Laser serv and other Undivided Normalized: laser serv and other undivided |
Device | Philips North America LLC | $129.27 | 1 | 2025 |
Source payment records
|
|||||
| COVERA Normalized: covera |
Device | Bard Peripheral Vascular, Inc. | $116.23 | 5 | 2025 |
Source payment records
|
|||||
| Fluency Endovascular Stent Graft Normalized: fluency endovascular stent graft |
Device | Bard Peripheral Vascular, Inc. | $113.47 | 4 | 2025 |
Source payment records
|
|||||
| IGT Devices Undivided Normalized: igt devices undivided |
Device | Philips North America LLC | $113.35 | 1 | 2025 |
Source payment records
|
|||||
| Cytal Normalized: cytal |
Device | Integra LifeSciences Corporation | $110.42 | 2 | 2025 |
Source payment records
|
|||||
| PRODIGY CATHETER Normalized: prodigy catheter |
Device | Imperative Care, Inc | $84.27 | 3 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $83.83 | 3 | 2025 |
Source payment records
|
|||||
| Venovo Normalized: venovo |
Device | Bard Peripheral Vascular, Inc. | $76.93 | 3 | 2025 |
Source payment records
|
|||||
| Integra Normalized: integra |
Device | Integra LifeSciences Corporation | $70.96 | 3 | 2025 |
Source payment records
|
|||||
| Integra Dermal Regeneration Template Normalized: integra dermal regeneration template |
Device | Integra LifeSciences Corporation | $70.96 | 3 | 2025 |
Source payment records
|
|||||
| PRIMATRIX Normalized: primatrix |
Device | Integra LifeSciences Corporation | $70.96 | 3 | 2025 |
Source payment records
|
|||||
| COR-KNOT Normalized: cor knot |
Device | LSI SOLUTIONS INC | $56.50 | 1 | 2025 |
Source payment records
|
|||||
| URGOK2 Normalized: urgok2 |
Device | Urgo Medical North America, LLC | $44.53 | 2 | 2025 |
Source payment records
|
|||||
| ROSEN Normalized: rosen |
Device | Cook Medical LLC | $40.96 | 2 | 2025 |
Source payment records
|
|||||
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $35.55 | 2 | 2025 |
Source payment records
|
|||||
| VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP Normalized: vashe wound solution 250 ml 8 5 fl oz flip top cap |
Device | Urgo Medical North America, LLC | $34.70 | 2 | 2025 |
Source payment records
|
|||||
| LYMPHA PRESS OPTIMAL PLUS(US) BT Normalized: lympha press optimal plus us bt |
Device | CashFlow Solutions, LLC | $31.41 | 2 | 2025 |
Source payment records
|
|||||
| PCD-51 731A (US) - White Normalized: pcd 51 731a us white |
Device | CashFlow Solutions, LLC | $31.41 | 2 | 2025 |
Source payment records
|
|||||
| PCD-52 737A (US) White Normalized: pcd 52 737a us white |
Device | CashFlow Solutions, LLC | $31.41 | 2 | 2025 |
Source payment records
|
|||||
| HOTSHOT CONTROLLER Normalized: hotshot controller |
Device | Imperative Care, Inc | $31.39 | 1 | 2025 |
Source payment records
|
|||||
| SET Aspirex S 10F 110cm Normalized: set aspirex s 10f 110cm |
Device | Bard Peripheral Vascular, Inc. | $29.54 | 3 | 2025 |
Source payment records
|
|||||
| FLEX Vessel Prep System Normalized: flex vessel prep system |
Device | VentureMed Group, Inc. | $28.97 | 1 | 2025 |
Source payment records
|
|||||
| METACROSS OTW Normalized: metacross otw |
Device | Terumo Medical Corporation | $26.86 | 1 | 2025 |
Source payment records
|
|||||
| R2P MISAGO Normalized: r2p misago |
Device | Terumo Medical Corporation | $26.86 | 1 | 2025 |
Source payment records
|
|||||
| ARTEGRAFT VASCULAR GRAFT Normalized: artegraft vascular graft |
Device | LeMaitre Vascular, Inc. | $26.78 | 1 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $25.04 | 1 | 2025 |
Source payment records
|
|||||
| Restrata Wound Matrix Normalized: restrata wound matrix |
Device | Acera Surgical, Inc. | $24.63 | 1 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $24.30 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $23.61 | 1 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $21.96 | 1 | 2025 |
Source payment records
|
|||||
| Conquest Normalized: conquest |
Device | Bard Peripheral Vascular, Inc. | $21.94 | 1 | 2025 |
Source payment records
|
|||||
| Altius Normalized: altius |
Device | Neuros Medical, Inc. | $20.77 | 1 | 2025 |
Source payment records
|
|||||
| Symvess Normalized: symvess |
Biological | Humacyte Global, Inc. | $19.11 | 1 | 2025 |
Source payment records
|
|||||
| URGOCLEAN AG Normalized: urgoclean ag |
Device | Urgo Medical North America, LLC | $17.73 | 1 | 2025 |
Source payment records
|
|||||
| Atlas Gold Normalized: atlas gold |
Device | Bard Peripheral Vascular, Inc. | $4.52 | 1 | 2025 |
Source payment records
|
|||||
| Pristine Normalized: pristine |
Device | Bard Peripheral Vascular, Inc. | $3.10 | 1 | 2025 |
Source payment records
|
|||||
| COOK CELECT Normalized: cook celect |
Device | Cook Medical LLC | $3.04 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 44 | 18 |
| Atorvastatin Calcium | Atorvastatin Calcium | 31 | suppressed |
| Xarelto | Rivaroxaban | 13 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $8,673.69 · 129 records | Integra LifeSciences Corporation | APLIGRAF, ARTEGRAFT VASCULAR GRAFT, ARTIX MT, AZUR CX DETACHABLE, Altius, Atlas Gold, CLOTTRIEVER BOLD CATHETER, COOK CELECT, COR-KNOT, COVERA, CT THROMBECTOMY SYSTEM KIT, Conquest, Cytal, ENDOCROSS Device, ENROUTE Transcarotid Neuroprotection System, ESPRIT, FLEX Vessel Prep System, FLOWTRIEVER CATHETER, S, Fluency Endovascular Stent Graft, HOTSHOT CONTROLLER, IGT Devices Undivided, Integra, Integra Dermal Regeneration Template, LEQVIO, LUTONIX Drug Coated Balloon, LYMPHA PRESS OPTIMAL PLUS(US) BT, Laser serv and other Undivided, METACROSS OTW, MicroMatrix, PCD-51 731A (US) - White, PCD-52 737A (US) White, PRIMATRIX, PRODIGY CATHETER, Penumbra System, Pristine, R2P MISAGO, ROSEN, Restrata Wound Matrix, SET Aspirex S 10F 110cm, SYMPHONY CATHETER, Serrantor, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Symvess, Torus Stent Graft System, URGOCLEAN AG, URGOK2, VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP, Venovo, ZENITH SPIRAL-Z, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error